MICU1 drives glycolysis and chemoresistance in ovarian cancer. - Test2 - elhamkhani - TriplyDB

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

http://www.wikidata.org/entity/Q33815720

about

Endoplasmic Reticulum-Mitochondria Calcium Communication and the Regulation of Mitochondrial Metabolism in Cancer: A Novel Potential Target.The Glycolytic Switch in Tumors: How Many Players Are Involved?UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.

P2860

Q41699680-0958F830-DAD0-433C-BDAC-A6208ED2A158 Q45419184-78A63612-0C35-4AF4-94AB-8AA102A23750 Q47156190-1E60116F-23F7-442D-AF7C-2A7FA9626B18

P2860

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

http://www.wikidata.org/entity/Q33815720

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@ast

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@en

type

label

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@ast

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@en

prefLabel

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@ast

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

@en

P1433

Q33815720-510528B2-9D8A-4EC7-852D-0D66BD9366C4

P1476

Q33815720-6E560C23-A259-4B5F-818E-68E047EC232D

P2093

Q33815720-08EA0B9D-A068-4627-9FE2-5F2E55AE3D49

Q33815720-2C39F505-A8B2-458E-BE99-DF2942DA1740

Q33815720-3A1FF091-C502-4470-942E-EA391164DB12

Q33815720-3C08310D-BB44-4B58-9105-472CC2DDBB49

Q33815720-465A1A4E-FF57-4BA0-B625-57ECCE62061E

Q33815720-58E0438B-9EF9-4FED-AD03-2D511BD286F0

Q33815720-5919605F-29ED-441E-B6D8-31BCD2A17683

Q33815720-6E3C50D9-A4FA-4BB7-82B4-4AF62EE415C0

Q33815720-73E8B7A4-F174-486D-BA46-371157E3FBD5

Q33815720-7FC3003D-BF18-424F-A8E1-1ECEBBFB80BC

P2860

Q33815720-041D7B78-E620-4FE9-8EF3-768838A333E6

Q33815720-0CEA3991-1F64-4920-86A5-5D225833B171

Q33815720-146BA794-F67A-4633-9D73-8CA5C85651FE

Q33815720-1814D23D-A20B-4AA7-AFDD-E14A1E711DD6

Q33815720-206835EE-06A5-49DC-8D38-747B2FDC0F4F

Q33815720-2A2AA1CD-15A9-43C1-A40D-01321A07EF6A

Q33815720-2D1BB3DE-7CF2-4431-8C75-D16158F22FF3

Q33815720-3AE3E40F-0C2B-4A2F-A3D6-B6E6A2ACBB60

Q33815720-3BC02362-77B6-4B0E-9908-D537A212F20F

Q33815720-3FEB5792-C29D-4C3B-AF04-3313702E5BB6

P2888

Q33815720-80D5EDA0-EF0D-4C88-BFF8-397FF8A193BB

P304

Q33815720-642997D6-552E-4ABE-9F3A-AE508696E991

P31

Q33815720-7D12BE97-FC16-4151-938F-BA4FC8B6DD93

P356

Q33815720-6536F56B-A90C-42B2-8A7A-0FF52B00364B

P407

Q33815720-0DC25C20-87EE-40D0-9107-B2EA4C32B4BC

P478

Q33815720-EEE24AA4-C9FA-4E62-A754-B4A27FC731D8

P50

Q33815720-24BCE510-D0C0-4C7E-AF92-14535C7DDA02

Q33815720-78B8B5EA-D9C6-43FC-8C43-7DF2C9342FC6

P577

Q33815720-3D769057-BFDF-4A7D-B41E-6C3E5163B642

P6179

Q33815720-84E374A4-8ED0-4521-ACA6-5007F9FF41E3

P698

Q33815720-312A99BA-3B4A-4C29-B742-93005DCC2438

P921

Q33815720-BD8F8CEA-6BD7-48B3-BD00-EC7E4350B9FE

P932

Q33815720-4A572351-2FA8-4C3F-8A57-A8665B3782C9

P356

P1433

Nature Communications

P1476

MICU1 drives glycolysis and chemoresistance in ovarian cancer

@en

P2093

Da Yang

http://www.w3.org/2001/XMLSchema#string

Danny Dhanasekaran

http://www.w3.org/2001/XMLSchema#string

Kai Ding

http://www.w3.org/2001/XMLSchema#string

Kathleen Moore

http://www.w3.org/2001/XMLSchema#string

Min Zhang

http://www.w3.org/2001/XMLSchema#string

Prabir K Chakraborty

http://www.w3.org/2001/XMLSchema#string

Priyabrata Mukherjee

http://www.w3.org/2001/XMLSchema#string

Resham Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Robert Mannel

http://www.w3.org/2001/XMLSchema#string

Rosemary Zuna

http://www.w3.org/2001/XMLSchema#string

P2860

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology

Hallmarks of Cancer: The Next Generation

How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models

Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase

MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake

MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival

Structural and mechanistic insights into MICU1 regulation of mitochondrial calcium uptake

MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity

EMRE is an essential component of the mitochondrial calcium uniporter complex

Targeting cellular metabolism to improve cancer therapeutics

P2888

P304

14634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS14634

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Muralidharan Jayaraman

Leonidas Tsiokas

P577

2017-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085459935

http://www.w3.org/2001/XMLSchema#string

P698

28530221

http://www.w3.org/2001/XMLSchema#string

P921

P932

5477507

http://www.w3.org/2001/XMLSchema#string